Insights

Why the Wesfarmers (ASX:WES) share price has been in focus this week

It’s been an interesting week for the Aussie conglomerate. Here are the details
The post Why the Wesfarmers (ASX:WES) share price has been in focus this week appeared first on The Motley Fool Australia. –

It’s been a big week for the Wesfarmers Limited (ASX: WES) share price.

Investors have been keeping a keen eye on shares in the Aussie conglomerate after various headlines.

Let’s take a look at why the Wesfarmers share price has received extra attention this past week.

What’s making the headlines?

Wesfarmers made headlines this week following its ‘sweetened’ bid to acquire Australian Pharmaceutical Industries Ltd (ASX: API).

The conglomerate has offered to buy 100% of API’s outstanding shares at $1.55 per share under a revised scheme arrangement.

At the time, Wesfarmers’ new offer represented a 22% premium on API’s closing price. Overall, the new bid values API’s equity at approximately$764 million.

API’s board unanimously recommended the revised bid, subject to parties entering a binding scheme implementation deed.

According to the Australian Financial Review’s Street Talk column, Wesfarmers has already begun its due diligence which will take approximately 4 weeks.

Before proceeding, the deal also requires clearance from the Australian Competition and Consumer Commission (ACCC).

Wesfarmers made its intentions about expanding into the beauty and pharmaceutical sector clear earlier this year.

The conglomerate lodged a $687 million takeover bid for API in July, which was rejected by the pharmaceutical company.

The renewed bid for API has also renewed speculation on other acquisitions Wesfarmers may pursue.

Snapshot of the Wesfarmers share price

Up until recently, the Wesfarmers share price was having a stellar year. However, in the past 3 weeks, shares in the conglomerate have fallen more than 14% from their record highs.

The sell-off coincides with the release of the company’s full-year report for FY21.

Wesfarmers recorded a 10% increase in revenue and an 18.8% jump in EBIT from continuing operations.

Other highlights from the company’s full-year report included:

EBIT (after interest on lease liabilities) up 20.7% to $3,550 million;
Net profit after tax rose 16.2% to $2,421 million;
Operating cash flows down 25.6% to $3,383 million;
Fully franked full-year dividend of 178 cents per share, up 17.1% year on year; and
Proposed $2.3 billion or $2.00 per share capital return to shareholders.

Despite falling in the past month, the Wesfarmers share price remains more than 12.5% higher for the year.

Shares in the conglomerate closed Friday’s trading session at $57.28, up 0.53% on the day.

The post Why the Wesfarmers (ASX:WES) share price has been in focus this week appeared first on The Motley Fool Australia.

Should you invest $1,000 in Wesfarmers right now?

Before you consider Wesfarmers, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Acquisitions for Wesfarmers and Domain, Telstra plans to grow and Myer back in profit. Scott Phillips on Nine’s Late News

The Wesfarmers (ASX:WES) share price rose after the API (ASX:API) bid
This year’s ASX 200 Santa Rally to get a whopping $84bn cash boost

These 3 ASX Healthcare shares have surged over 10% today

Why Anteotech, API, Myer, & Whitehaven Coal shares are charging higher

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!